CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia

Abroad (travel likely)RecruitingPHASE2

Conditions

Acute Lymphoblastic Leukemia · Refractory Acute Lymphoblastic Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Contact: Study coordinator (Aimee Talleur, MD) · referralinfo@stjude.org · 866-278-5833
Contact: Principal Investigator (Aimee Talleur, MD)

Study leads

Aimee Talleur, MD
Principal Investigator
St. Jude Children's Research Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia · Recurrent Acute Lymphoblastic Leukemia · Recurrent B Acute Lymphoblastic Leukemia

Abroad (travel likely)RecruitingPHASE1

Memphis, United States

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

Acute Leukemia of Ambiguous Lineage · Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE2

Seattle, United States

Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma

Acute Lymphoblastic Leukemia · Lymphoblastic Lymphoma

Abroad (travel likely)RecruitingPHASE2

Charlotte, United States · Tulsa, United States

PTCy and ATG for MSD and MUD Transplants

Acute Myeloid Leukemia · Acute Lymphoblastic Leukemia · Myelodysplastic Syndromes

Abroad (travel likely)RecruitingPHASE1, PHASE2

Rio de Janeiro, Brazil